Comparison of HIV prevalence, incidence, and viral load suppression in Zambia population-based HIV impact assessments from 2016 and 2021

Author:

Mulenga Lloyd B.123,Hines Jonas Z.4,Stafford Kristen A.5,Dzekedzeke Kumbutso6,Sivile Suilanji12,Lindsay Brianna5,Chola Mumbi6,Ussery Faith7,Patel Hetal K.7,Abimiku Alash’le5,Birhanu Sehin7,Minchella Peter A.4,Stevens Thomas4,Hanunka Brave4,Chisenga Tina1,Shibemba Aaron2,Fwoloshi Sombo12,Siame Mwiche1,Mutukwa John1,Chirwa Lameck2,Siwingwa Mpanji23,Mulundu Gina23,Agbakwuru Chinedu5,Mapondera Prichard6,Detorio Mervi7,Agolory Simon G.4,Monze Mwaka12,Bronson Megan7,Charurat Man E.5,

Affiliation:

1. Ministry of Health

2. University Teaching Hospital

3. University of Zambia, School of Medicine

4. U.S. Centers for Disease Control and Prevention, Lusaka, Zambia

5. Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA

6. Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation—an affiliate of the University of Maryland, Baltimore, Lusaka, Zambia

7. U.S. Centers for Disease Control and Prevention, Atlanta, USA.

Abstract

Background: The Zambian government has implemented a public health response to control the HIV epidemic in the country. Zambia conducted a population-based HIV impact assessment (ZAMPHIA) survey in 2021 to assess the status of the HIV epidemic to guide its public health programs. Methods: ZAMPHIA 2021 was a cross-sectional two-stage cluster sample household survey among persons aged ≥15 years conducted in Zambia across all 10 provinces. Consenting participants were administered a standardized questionnaire and whole blood was tested for HIV according to national guidelines. HIV-1 viral load (VL), recent HIV infection, and antiretroviral medications were tested for in HIV-seropositive samples. Viral load suppression (VLS) was defined as <1000 copies/ml. ZAMPHIA 2021 results were compared to ZAMPHIA 2016 for persons aged 15–59 years (i.e., the overlapping age ranges). All estimates were weighted to account for nonresponse and survey design. Results: During ZAMPHIA 2021, of 25 483 eligible persons aged ≥15 years, 18 804 (73.8%) were interviewed and tested for HIV. HIV prevalence was 11.0% and VLS prevalence was 86.2% overall, but was <80% among people living with HIV aged 15–24 years and in certain provinces. Among persons aged 15–59 years, from 2016 to 2021, HIV incidence declined from 0.6% to 0.3% (P-value: 0.07) and VLS prevalence increased from 59.2% to 85.7% (P-value: <0.01). Discussion: Zambia has made substantial progress toward controlling the HIV epidemic from 2016 to 2021. Continued implementation of a test-and-treat strategy, with attention to groups with lower VLS in the ZAMPHIA 2021, could support reductions in HIV incidence and improve overall VLS in Zambia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3